Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T13:26:46.812Z.
Calculation as of: 2026-10-06T13:26:46.812Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a63c12ce7055b0216585e16b4e08b2fd6453147ab6d4be874ec80e726ee32667
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$134.74M
EV/EBIT Ratio
N/A
TTM Avg
60.31x
3Y Avg
490.71x
5Y Avg
419.04x
Market Cap
$138.26M
EV/EBIT Ratio
N/A
TTM Avg
734.52x
3Y Avg
360.78x
5Y Avg
245.93x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Health Catalyst, Inc. (HCAT) | $130.05M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | N/A | 3.95x | 3.95x | 3.95x |
| LifeMD, Inc. (LFMD)vs › | $131.55M | N/A | 204.78x | 204.78x | 204.78x |
| Cibus, Inc. (CBUS)vs › | $128.24M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | N/A | 60.31x | 490.71x | 419.04x |
| enGene Holdings Inc. (ENGN)vs › | $125.27M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.26M | N/A | 734.52x | 360.78x | 245.93x |
| TuHURA Biosciences, Inc. (HURA)vs › | $119.09M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $118.63M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
